Market Cap

Fate Therapeutics, Inc. Market Capitalization:

$113.8 Million

USD as of Jan. 1, 2026

business Fate Therapeutics, Inc. Company Profile

Fate Therapeutics, Inc. Main Stock Listing

NASDAQ: FATE

Market Capitalization History of Fate Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Fate Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $113.8 M -24.88%
Jan. 1, 2025 $151.5 M -59.25%
Jan. 1, 2024 $371.7 M -33.04%
Jan. 1, 2023 $555.1 M -86.22%
Jan. 1, 2022 $4.03 B -54.20%
Jan. 1, 2021 $8.80 B 257.37%
Jan. 1, 2020 $2.46 B 67.50%
Jan. 1, 2019 $1.47 B 65.65%
Jan. 1, 2018 $887.1 M 234.80%
Jan. 1, 2017 $265.0 M 26.98%
Jan. 1, 2016 $208.7 M -57.84%
Jan. 1, 2015 $495.0 M -17.74%
Jan. 1, 2014 $601.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Fate Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Fate Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: FATE

Stock: FSX: F6T

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.